NEPOCEF – CV 325 TABLETS, 5*10 s

Description

Ingredients & Composition:

Each Nepocef-CV 162.5 mg uncoated tablet contains

Cefpodoxime Proxetil IP equivalent to
Cefpodoxime               100 mg
Potassium Clavulanate diluted IP equivalent to
Clavulanic acid            62.5 mg

Each Nepocef-CV 325 mg uncoated tablet contains

Cefpodoxime Proxetil IP equivalent to
Cefpodoxime               200 mg
Potassium Clavulanate diluted IP equivalent to
Clavulanic acid            125 mg
Flavoured tablets

Description / Action: 

Nepocef-CV tablets for dogs contain cefpodoxime proxetil potentiated with Clavulanic acid. Cefpodoxime Proxetil inhibits the cell wall synthesis of bacteria. Clavulanic acid in Nepocef-CV overcomes antibiotic resistance in bacteria that secretes B-lactamase.

Compliance is always a major concern in treating Canine Pyoderma. Nepfocef-CV tablets assure compliance with its small flavoured, double strength tablets that benefits dogs, pet parents & vets